StockData
enGene Therapeutics Inc. logo

enGene Therapeutics Inc. (ENGN) income statement

ENGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends October 31Also trades as ENGNW
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 8, 2026Score 3/30
$1.74−0.02 (-1.14%)

Close on Nov 20, 2026Market cap $116.61MP/E –Yield 0.00%

See a number that looks wrong?